C9orf72 arginine-rich dipeptide proteins interact with ribosomal proteins in vivo to induce a toxic translational arrest that is rescued by eIF1A

Thomas G. Moens(Allen Institute for Brain Science), Teresa Niccoli(UK Dementia Research Institute), Katherine Wilson(UK Dementia Research Institute), Magda L. Atilano(UK Dementia Research Institute), Nicol Birsa(National Hospital for Neurology and Neurosurgery), Lauren M. Gittings(UK Dementia Research Institute), Benedikt V. Hölbling(UK Dementia Research Institute), Miranda C. Dyson(UK Dementia Research Institute), Annora Thoeng(UK Dementia Research Institute), Jacob Neeves(National Hospital for Neurology and Neurosurgery), Idoia Glaria(UK Dementia Research Institute), Lu Yu(Institute of Cancer Research), Julia Bussmann(University of Münster), Erik Storkebaum(Radboud University Nijmegen), Mercedes Pardo(Institute of Cancer Research), Jyoti S. Choudhary(Institute of Cancer Research), Pietro Fratta(National Hospital for Neurology and Neurosurgery), Linda Partridge(Max Planck Institute for Biology of Ageing), Adrian M. Isaacs(UK Dementia Research Institute)
Acta Neuropathologica
January 2, 2019
Cited by 124Open Access
Full Text

Abstract

A GGGGCC hexanucleotide repeat expansion within the C9orf72 gene is the most common genetic cause of both amyotrophic lateral sclerosis and frontotemporal dementia. Sense and antisense repeat-containing transcripts undergo repeat-associated non-AUG-initiated translation to produce five dipeptide proteins (DPRs). The polyGR and polyPR DPRs are extremely toxic when expressed in Drosophila neurons. To determine the mechanism that mediates this toxicity, we purified DPRs from the Drosophila brain and used mass spectrometry to identify the in vivo neuronal DPR interactome. PolyGR and polyPR interact with ribosomal proteins, and inhibit translation in both human iPSC-derived motor neurons, and adult Drosophila neurons. We next performed a screen of 81 translation-associated proteins in GGGGCC repeat-expressing Drosophila to determine whether this translational repression can be overcome and if this impacts neurodegeneration. Expression of the translation initiation factor eIF1A uniquely rescued DPR-induced toxicity in vivo, indicating that restoring translation is a potential therapeutic strategy. These data directly implicate translational repression in C9orf72 repeat-induced neurodegeneration and identify eIF1A as a novel modifier of C9orf72 repeat toxicity.


Related Papers

No related papers found

Powered by citation graph analysis